Impress Secures €40 Million to Expand Dental AI Network
Clinic operators should track how AI-driven remote monitoring is being used to scale multi-country healthcare networks.
Updated on Oct. 27, 2026 in Healthcare
Live Poll
Do you trust artificial intelligence-powered medical platforms to provide high-quality, safe healthcare?
Dental technology company Impress has secured a €40 million venture debt loan from the European Investment Bank to accelerate its AI platform development and European network expansion. The firm, which operates over 110 global clinics, plans to scale its operations further into Northern Europe following a year of positive EBITDA performance.
Why it matters
This capital injection allows Impress to double down on a hybrid care model that leverages proprietary AI to reduce in-person clinic visits. As healthcare providers look to improve unit economics, the scaling of automated treatment planning has become a central strategy for maintaining growth while managing overhead.
Impress secured €40 million in venture debt, building on €110 million raised in 2024, to support a network of over 110 clinics. The company reports 2025 revenue of €103 million and projects an increase to €145 million in 2026.
The players
Impress
A health-tech company operating a hybrid dental clinic network across 10 countries using AI-integrated treatment planning.
European Investment Bank
The lending arm of the European Union that provides financing for projects aligned with the economic policy objectives of the bloc.
DrSmile
A dental alignment provider acquired by Impress in 2024 to consolidate its market position.
The details
Impress utilizes a hybrid model combining in-person clinical care with continuous monitoring through a proprietary AI platform. By employing AI-assisted treatment planning and 3D intraoral scanning, the company manages patient tracking remotely to maintain clinical oversight. This digital infrastructure supports the company's ability to scale across 10 countries while maintaining central quality control over treatment plans.
Timeline
2019: Impress is founded in Barcelona.
2023: Operations commence in Germany, the Netherlands, and the UK.
2024: Impress acquires DrSmile and raises €110 million in financing.
2026: The company secures €40 million in European Investment Bank venture debt.
Market Landscape
This venture debt facility follows the European Investment Bank's standard pattern of scaling health-tech entities that digitize traditionally capital-intensive service models. The move mirrors a broader industry trend of consolidating fragmented dental care providers through unified AI-based monitoring.
Operators in the dental and clinical space should monitor how Impress utilizes AI to scale patient volume without proportional increases in physical infrastructure. The shift toward remote monitoring and AI-assisted planning suggests a move toward higher-margin, tech-driven service models.
The takeaway
The Impress financing signals that institutional lenders are prioritizing clinic networks with integrated proprietary software over traditional multi-site operators. Owners should evaluate whether their existing patient databases can support similar automated monitoring tools to improve clinical efficiency.
Further reading
For broader trends in medical practice automation, explore our Healthcare section.
Live Poll
Do you trust artificial intelligence-powered medical platforms to provide high-quality, safe healthcare?
